|
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who
|
Z01 BC 010581
|
$34,098
|
$13,639
|
Warren, Katherine
|
CCR (NCI)
|
|
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by[18F-]- FDG PET
|
Z01 BC 010582
|
$34,098
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
Z01 BC 010585
|
$17,049
|
$17,049
|
Warren, Katherine
|
CCR (NCI)
|
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric
|
Z01 BC 010584
|
$34,098
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
Z01 BC 010709
|
$34,098
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,395,646
|
$69,782
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Apoptosis Mechanisms and Human Cancer
|
5R01CA082197-08
|
$262,741
|
$65,685
|
WANG, HONG-GANG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Assessment and Optimization for Radiation Therapy
|
5R01CA050628-18
|
$373,347
|
$37,335
|
NIEMIERKO, ANDRZEJ
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Calpain Inhibitors for Cancer Related Neuropathies
|
1R43CA121653-01A1
|
$187,907
|
$187,907
|
WEBB, ROBERT
|
AXONA, INC.
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
$56,318
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$1,379
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$2,323
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$115,265
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant P30 CA77598-06
|
3P30CA077598-10S1
|
$89,196
|
$892
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cancer Center Support Grant P30 CA77598-06
|
3P30CA077598-10S2
|
$120,409
|
$1,204
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cancer Center Support Grant P30 CA77598-06
|
5P30CA077598-10
|
$3,404,916
|
$34,049
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Chemotactic Formylpeptide Receptor Development/Progression Malignant Human Gliom
|
Z01 BC 010724
|
$89,822
|
$53,893
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Chemotherapy Adjuvants
|
Z01 BC 010382
|
$273,819
|
$136,910
|
Moschel, Robert
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
Z01 SC 010354
|
$138,299
|
$41,490
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
Z01 BC 010627
|
$102,568
|
$5,128
|
Figg, William
|
CCR (NCI)
|
|
Combination of Radiation with Multi-Target Molecular Therapy for Cancer
|
Z01 BC 010658
|
$237,135
|
$47,427
|
Capala, Jacek
|
CCR (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$175,175
|
$175,175
|
Khan, Javed
|
CCR (NCI)
|
|
Connecting PTEN and NF2 cancer predisposition syndromes
|
5R01CA107201-03
|
$254,494
|
$254,494
|
GEORGESCU, MARIA-MAGDALENA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental Th
|
Z01 BC 010541
|
$76,229
|
$76,229
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Recombinant Toxins for Treatment of Patients with Hematologic Mali
|
Z01 BC 010301
|
$405,903
|
$4,059
|
Kreitman, Robert
|
CCR (NCI)
|
|
Developmental Signal Transduction in Xenopus Oocytes and Embryos
|
Z01 BC 010006
|
$689,247
|
$206,774
|
Daar, Ira
|
CCR (NCI)
|
|
Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therapi
|
Z01 BC 005673
|
$776,194
|
$155,239
|
Keefer, Larry
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
Z01 BC 004517
|
$864,697
|
$86,470
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$581,400
|
Balis, Frank
|
CCR (NCI)
|
|
Dynamic Regulation of Ras via the NF1 tumor Suppressor
|
5R01CA111754-03
|
$280,637
|
$280,637
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
1R01CA129814-01
|
$302,105
|
$302,105
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Exploration of the Translational/Therapeutic Potential of Stem Cell B
|
Z01 BC 010839
|
$1,611,664
|
$1,611,664
|
Fine, Howard
|
CCR (NCI)
|
|
High Throughput MR Microscopy for Cancer Screening
|
1R43CA130870-01
|
$99,998
|
$25,000
|
Forbes, Bryn
|
MRPATH, INC.
|
|
Histologic and Molecular Characterization of Solid Pediatric Tumors
|
Z01 SC 009431
|
$162,283
|
$8,114
|
Tsokos, Maria
|
CCR (NCI)
|
|
Id2 in cell cycle regulation and cancer
|
5R01CA085628-08
|
$361,563
|
$180,782
|
IAVARONE, ANTONIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
Z01 SC 010366
|
$218,969
|
$10,948
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
Z01 BC 010539
|
$304,916
|
$60,983
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes
|
Z01 BC 005652
|
$505,750
|
$50,575
|
Dean, Michael
|
CCR (NCI)
|
|
Imaging characteristics of Diffuse Pontine Gliomas after Radiation Therapy
|
Z01 BC 010589
|
$34,098
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
Immunobiology and Immunotherapy of Pediatric Tumors
|
Z01 SC 010289
|
$548,542
|
$109,708
|
Mackall, Crystal
|
CCR (NCI)
|
|
In Vivo MRI imaging of single metastatic cells
|
Z01 BC 010731
|
$105,828
|
$84,662
|
Kelly, Kathleen
|
CCR (NCI)
|
|
Inhibition of Grb2 mediated cellular signaling
|
Z01 BC 010704
|
$19,520
|
$4,880
|
Roller, Peter
|
CCR (NCI)
|
|
Matrix Metalloproteinases Gordon Conference
|
5R13CA115182-02
|
$5,000
|
$1,250
|
BLOBEL, CARL
|
GORDON RESEARCH CONFERENCES
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$286,829
|
$28,683
|
Anderson, Lucy
|
CCR (NCI)
|
|
MLK3 function in neurofibromatosis tumor cells
|
5R01CA112399-03
|
$244,195
|
$244,195
|
Kyriakis, John
|
NEW ENGLAND MEDICAL CENTER HOSPITALS
|
|
Modeling of the structure and functional mechanisms of voltage-gated channels
|
Z01 BC 010721
|
$183,149
|
$54,945
|
Guy, H. Robert
|
CCR (NCI)
|
|
Molecular Analysis of Breast Cancer Metastasis to the Brain
|
Z01 BC 010538
|
$390,241
|
$117,072
|
Steeg, Patricia
|
CCR (NCI)
|
|
Molecular and Genetic Characterization of Human Gliomas to Identify New Targets
|
Z01 SC 010100
|
$1,564,262
|
$1,564,262
|
Fine, Howard
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $14,289,345
|